Nucleolar protein NPM interacts with HDM2 and protects tumor suppressor protein p53 from HDM2-mediated degradation

被引:349
|
作者
Kurki, S
Peltonen, K
Latonen, L
Kiviharju, TM
Ojala, PM
Meek, D
Laiho, M
机构
[1] Univ Helsinki, Biomedicum, Haartman Inst, FIN-00014 Helsinki, Finland
[2] Univ Helsinki, Biomedicum, Mol Canc Biol Res Program, FIN-00014 Helsinki, Finland
[3] Univ Helsinki, Cent Hosp, Diagnost Lab, FIN-00014 Helsinki, Finland
[4] Univ Dundee, Ninewells Hosp & Med Sch, Biomed Res Ctr, Dundee DD1 9SY, Scotland
基金
芬兰科学院;
关键词
D O I
10.1016/S1535-6108(04)00110-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Nucleophosmin (NPM, B23) is an abundant nucleolar phosphoprotein involved in ribosome biogenesis, and interacts with tumor suppressor proteins p53 and Rb. Here we show that NPM is a UV damage response protein that undergoes nucleoplasmic redistribution and regulates p53 and HDM2 levels and their interaction. By utilizing RNAi approaches and analyses of endogenous and ectopically expressed proteins, we demonstrate that NPM binds HDM2 and acts as a negative regulator of p53-HDM2 interaction. Viral stress, enforced by expression of Kaposi's sarcoma virus K cyclin, causes NPM redistribution, K cyclin-NPM association, and p53 stabilization by dissociation of HDM2-p53 complexes. The results demonstrate novel associations of HDM2 and K cyclin with NPM and implicate NPM as a crucial controller of p53 through inhibition of HDM2.
引用
收藏
页码:465 / 475
页数:11
相关论文
共 50 条
  • [31] Regulation of hdm2 by stress-induced hdm2alt1 in tumor and nontumorigenic cell lines correlating with p53 stability
    Dias, Chrisanne S.
    Liu, Yan
    Yau, Amy
    Westrick, Lindsay
    Evans, Susan C.
    CANCER RESEARCH, 2006, 66 (19) : 9467 - 9473
  • [32] 5-Deazaflavin derivatives as inhibitors of p53 ubiquitination by HDM2
    Dickens, Michael P.
    Roxburgh, Patricia
    Hock, Andreas
    Mezna, Mokdad
    Kellam, Barrie
    Vousden, Karen H.
    Fischer, Peter M.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2013, 21 (22) : 6868 - 6877
  • [33] The central region of HDM2 provides a second binding site for p53
    Yu, GW
    Rudiger, S
    Veprintsev, D
    Freund, S
    Fernandez-Fernandez, MR
    Fersht, AR
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (05) : 1227 - 1232
  • [34] In Silico Improvement of β3-Peptide Inhibitors of p53•hDM2 and p53•hDMX
    Michel, Julien
    Harker, Elizabeth A.
    Tirado-Rives, Julian
    Jorgensen, William L.
    Schepartz, Alanna
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2009, 131 (18) : 6356 - +
  • [35] Nucleolin inhibits Hdm2 by multiple pathways leading to p53 stabilization
    Saxena, A.
    Rorie, C. J.
    Dimitrov, D.
    Daniely, Y.
    Borowiec, J. A.
    ONCOGENE, 2006, 25 (55) : 7274 - 7288
  • [36] Cell-Permeable β-Peptide Inhibitors of p53/hDM2 Complexation
    Harker, Elizabeth A.
    Schepartz, Alanna
    CHEMBIOCHEM, 2009, 10 (06) : 990 - 993
  • [37] Reactivation of p53 in cells expressing hepatitis B virus X-protein involves p53 phosphorylation and a reduction of Hdm2
    Wang, Jin-Hee
    Yun, Chawon
    Kim, Sujeong
    Chae, Sunyoung
    Lee, Young Ik
    Kim, Wook-Hwan
    Lee, Jae-Ho
    Kim, Wankee
    Cho, Hyeseong
    CANCER SCIENCE, 2008, 99 (05) : 888 - 893
  • [38] Nucleolin inhibits Hdm2 by multiple pathways leading to p53 stabilization
    A Saxena
    C J Rorie
    D Dimitrova
    Y Daniely
    J A Borowiec
    Oncogene, 2006, 25 : 7274 - 7288
  • [39] The Expression and Function of NUMB in Endometrial Cancer and the Interaction with HDM2 and P53
    Wang, Chao
    Feng, Weiwei
    Zhang, Chuyao
    JOURNAL OF CANCER, 2015, 6 (10): : 1030 - 1040
  • [40] A regulatory loop composed of RAP80-HDM2-p53 provides RAP80 enhanced p53 degradation by HDM2 in response to DNA damage
    Menendez, Daniel
    Yan, Jun
    Yang, Xiao-Ping
    Jetten, Anton M.
    Resnick, Michael
    CANCER RESEARCH, 2009, 69